NYSE:MDT - Medtronic Stock Price, News, & Analysis

Medtronic trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDT."

Medtronic declared a quarterly dividend on Friday, December 7th. Shareholders of record on Friday, December 28th will be given a dividend of $0.50 per share on Friday, January 18th. This represents a $2.00 annualized dividend and a yield of 2.13%. The ex-dividend date of this dividend is Thursday, December 27th. View Medtronic's Dividend History.

Medtronic announced that its Board of Directors has initiated a stock repurchase plan on Thursday, October 5th 2017, which permits the company to repurchase $5,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to repurchase up to 49% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company's leadership believes its shares are undervalued.

Medtronic PLC (NYSE:MDT) released its quarterly earnings results on Tuesday, November, 20th. The medical technology company reported $1.22 EPS for the quarter, topping analysts' consensus estimates of $1.15 by $0.07. The medical technology company earned $7.48 billion during the quarter, compared to analyst estimates of $7.35 billion. Medtronic had a return on equity of 13.51% and a net margin of 7.44%. The company's quarterly revenue was up 6.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.07 earnings per share. View Medtronic's Earnings History.

Medtronic is scheduled to release their next quarterly earnings announcement on Tuesday, February 19th 2019. View Earnings Estimates for Medtronic.

Medtronic issued an update on its third quarter earnings guidance on Tuesday, November, 20th. The company provided earnings per share guidance of $1.23-1.25 for the period. Medtronic also updated its FY 2019 guidance to $5.10-5.15 EPS.

19 Wall Street analysts have issued 1 year price objectives for Medtronic's shares. Their predictions range from $88.00 to $120.00. On average, they expect Medtronic's stock price to reach $104.8611 in the next twelve months. This suggests a possible upside of 11.9% from the stock's current price. View Analyst Price Targets for Medtronic.

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last year. There are currently 6 hold ratings, 12 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Medtronic.

News stories about MDT stock have trended positive on Sunday, according to InfoTrie Sentiment. The research firm scores the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Medtronic earned a news impact score of 3.0 on InfoTrie's scale. They also gave news coverage about the medical technology company a news buzz of 8.0 out of 10, meaning that recent press coverage is very likely to have an effect on the company's share price in the next several days.

Some companies that are related to Medtronic include Varian Medical Systems (VAR), SONOVA HLDG AG/ADR (SONVY), Masimo (MASI), LivaNova (LIVN), GETINGE AB/ADR (GNGBY), NxStage Medical (NXTM), CONMED (CNMD), AxoGen (AXGN), Natus Medical (BABY), Viewray (VRAY), Cutera (CUTR), BioLife Solutions (BLFS), Semler Scientific (SMLR), Rockwell Medical (RMTI) and Fonar (FONR).

Medtronic's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (8.10%), Vanguard Group Inc (8.15%), BlackRock Inc. (7.21%), Massachusetts Financial Services Co. MA (4.25%), Franklin Resources Inc. (2.08%) and Dodge & Cox (1.31%). Company insiders that own Medtronic stock include Bradley E Lerman, Bryan C Hanson, Carol A Surface, Geoffrey Martha, Hoedt Rob Ten, Hooman Hakami, James T Lenehan, Michael J Coyle, Omar Ishrak, Richard H Anderson and Richard Kuntz. View Institutional Ownership Trends for Medtronic.

MDT stock was sold by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Capital Research Global Investors, Mitsubishi UFJ Trust & Banking Corp, The Manufacturers Life Insurance Company, Sanders Capital LLC, Dodge & Cox, Massachusetts Financial Services Co. MA and Wells Fargo & Company MN. Company insiders that have sold Medtronic company stock in the last year include Bradley E Lerman, Carol A Surface, Geoffrey Martha, Hooman Hakami, James T Lenehan, Michael J Coyle and Richard Kuntz. View Insider Buying and Selling for Medtronic.

MDT stock was acquired by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Nordea Investment Management AB, Pendal Group Ltd, Renaissance Technologies LLC, Man Group plc, American Century Companies Inc., FMR LLC and Marshall Wace North America L.P.. View Insider Buying and Selling for Medtronic.

Shares of MDT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MDT stock can currently be purchased for approximately $93.72.

Medtronic has a market capitalization of $125.87 billion and generates $29.95 billion in revenue each year. The medical technology company earns $3.10 billion in net income (profit) each year or $4.77 on an earnings per share basis. Medtronic employs 86,000 workers across the globe.

The official website for Medtronic is http://www.medtronic.com.

Medtronic's mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The medical technology company can be reached via phone at 353-1438-1700 or via email at [email protected]